Evidence map›Paper›PMID 39804670›Full record

ReviewToxicological sciences : an official journal of the Society of Toxicology2025

A perspective review on factors that influence mutagenicity in medicinal plants and their health implications.

Victoria Fasiku, Doreen Kyagaba, Atlehang Hlalele, Ayodeji Adegoke, Ochuko L Erukainure, Mamello Sekhoacha

Abstract readReview
In one paragraph

Review in Toxicological sciences : an official journal of the Society of Toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Victoria FasikuDepartment of Pharmacology, University of the Free State, Bloemfontein 9300, South Africa.
Doreen KyagabaDepartment of Pharmacology, University of the Free State, Bloemfontein 9300, South Africa.
Atlehang HlaleleDepartment of Pharmacology, University of the Free State, Bloemfontein 9300, South Africa.
Ayodeji AdegokeDepartment of Pharmacology, University of the Free State, Bloemfontein 9300, South Africa.
Ochuko L ErukainureLaser Research Center, Faculty of Health Sciences, University of Johannesburg, Doornfontein 2028, South Africa.
Mamello SekhoachaDepartment of Pharmacology, University of the Free State, Bloemfontein 9300, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medicinal plants are products from natural sources that have found relevance in medicine for several decades. They are rich in bioactive compounds; thus, they are widely used to treat different ailments globally. Medicinal plants have provided hope for the healthcare industry as most are used to synthesize modern medicines currently used in the treatment of various diseases. However, there are still concerns with respect to the mutagenic properties of medicinal plants. Over the years, researchers have embarked on various studies aimed at investigating the mutagenicity of several medicinal plants found in different regions of the world. In this review, we discussed factors that may influence plant mutagenicity and the findings of in vitro and in vivo mutagenicity studies of several medicinal plants from across the globe. In addition, this review considers the potential health implications of mutagenic medicinal plants and safety measures that can be used to mitigate mutagenesis in medicinal plants. To achieve this, we searched for articles reporting on medicinal plants and mutagenesis on the PubMed, Scopus, and Web of Science databases. Several journal articles reported on the mutagenicity of some medicinal plants; however, it was observed that the majority of the articles reported the nonmutagenicity of medicinal plants. The findings from these studies imply that medicinal plants have good prospects in treating diseases and that they are clinically relevant. However, these reports will require further validation to determine their safety for human use as limited in vivo studies were conducted and there are no clinical safety reports for any of the plants discussed in this review.

Indexed as

MutagenesisMutagensPlants, MedicinalAnimalsHumansMutagenicity TestsRisk AssessmentMutagenscarcinogenesisgenotoxicitymedicinal plantsmutagenesissafety

Identifiers

PMID39804670
PMCPMC11939080

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.